Grant Calls

Grant Calls Detail

Singapore - South Korea (A*STAR_KHIDI) Joint Grant Call

Published on : 23-May-2014

 

Singapore and South Korea signed a Memorandum of Understanding (MOU) in Dec 2013 to promote talent exchange and development, and facilitate the commercialisation of joint projects. As part of the collaboration, the A*STAR-KHIDI Joint Research Fund of US$5 million has been established.

In this joint call, fund from KHIDI would be used to fund Korean SMEs looking to Singapore to address their technology gaps; fund from Singapore will support local research performers in the collaboration.

Applications for the Joint Grant are restricted to Korean companies in the following industries:

1.     Medical Technology

2.     Pharmaceutical

3.     Biologics

4.     Personal Care

5.     Food and Nutrition

 

Deliverables of the project below:

1.     Korean companies to be funded should develop proposals with a view of setting up their business in Singapore within 3 years of grant.

2.     Proposals developed should work towards filing their products in Singapore and launch out to the region.

 

Eligibility Criteria:

1.     There must be a ROK counterpart, screened and approved by KHIDI

2.     There must be at least 1 Singapore public research performer (not pertaining to A*STAR) involved in the project. Allied health members from Singapore public hospitals are eligible for the grant as well.

 

Funding Quantum:

1.     Each project could be entitled a funding quantum up to USD$300K up to 3 years. The disbursement of fund per year is subjected to approval only if project milestones are met.

2.     The fund from KHIDI will support activities from ROK counterparts; fund from Singapore will support public research performers based locally.

 

Please refer to the links to the white papers of the shortlisted Korean companies below: (under Click Here) 

Category

No

Company

Manager

Title (White-paper)

White Paper

Webpage

Medical Devices

1

GENCURIX Inc.

Ahn, Joon-Young

Market Development Strategy for GenesWell™ DX BCT in Southeast Asia

Click Here

http://gencurix.com/index.php

2

HANDOK Inc.

Park, Jae-hyung

Pre-clinical Evaluation of the Renal Denervation System for Resistant Hypertension

Click Here

http://www.handok.co.kr/english/

3

Charm Engineering Co., Ltd

Kim, Kwang-moo

Development of a Diagnosis System for Depth of Anesthesia and Pain Monitoring System

Click Here

http://www.charmeng.com/english/

4

GEMSS Co., Ltd

Lee, Tae-bum

Development of Imaging Equipment for Ophthalmology Disease Screening

Click Here

http://www.gemss-medical.com/eng/html/main/index.asp

5

Cellumed Co., Ltd

Lee, Seong-baek

Development of Bovine Originated Xenograft with Collagen Incorporated Porous Structure

Click Here

http://www.kbbcom.co.kr/

6

L&C BIO

Kim, Hyung-gu

Development of Micronized Acellular Dermal Filler which is Enhanced in Bio-Compatibility and Duration by Special Cross-Linking with Hyaluronic Acid

Click Here

http://www.lncbio.co.kr/index_eng.html

Pharma

7

BMI Inc.

Chang, Chan-il

Therapeutics Development for Idiopathic Pulmonary Fibrosis using BMT 101 - A Pre-validated Oligonucleotide Drug Inhibitor

Click Here

http://www.bmtlab.co.kr/labkm/

 

Submissions:

1.      Softcopy submission

a.      Word document (without signatures)

b.      Scanned hardcopy (complete with both sides’ signatories) in PDF

2.      Hardcopy submission

All application forms should reach RSO at rso-astar@ntu.edu.sg by 27 June 2014, 5pm to obtain the appropriate endorsements from Director, RSO. Queries can be directed to rso-astar@ntu.edu.sg or kegpeisi@ntu.edu.sg.

Click here for more information of the grant call.